• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Microbiol Spectr . Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile

tetano

Editor, Senior Moderator
Microbiol Spectr


. 2022 Mar 30;e0273221.
doi: 10.1128/spectrum.02732-21. Online ahead of print.
Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile


Mohammad Alkhatib[SUP] 1 [/SUP], Romina Salpini[SUP] 1 [/SUP], Luca Carioti[SUP] 1 [/SUP], Francesca Alessandra Ambrosio[SUP] 2 [/SUP], Stefano D'Anna[SUP] 1 [/SUP], Leonardo Duca[SUP] 1 [/SUP], Giosuè Costa[SUP] 2 3 [/SUP], Maria Concetta Bellocchi[SUP] 1 [/SUP], Lorenzo Piermatteo[SUP] 1 [/SUP], Anna Artese[SUP] 2 3 [/SUP], Maria Mercedes Santoro[SUP] 1 [/SUP], Stefano Alcaro[SUP] 2 3 [/SUP], Valentina Svicher[SUP] #[/SUP][SUP] 4 [/SUP], Francesca Ceccherini-Silberstein[SUP] #[/SUP][SUP] 1 [/SUP]



Affiliations

Abstract

The process of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genetic diversification is still ongoing and has very recently led to the emergence of a new variant of concern (VOC), defined as Omicron or B.1.1.529. Omicron VOC is the most divergent variant identified so far and has generated immediate concern for its potential capability to increase SARS-CoV-2 transmissibility and, more worryingly, to escape therapeutic and vaccine-induced antibodies. Nevertheless, a clear definition of the Omicron VOC mutational spectrum is still missing. Herein, we provide a comprehensive definition and functional characterization (in terms of infectivity and/or antigenicity) of mutations characterizing the Omicron VOC. In particular, 887,475 SARS-CoV-2 Omicron VOC whole-genome sequences were retrieved from the GISAID database and used to precisely define its specific patterns of mutations across the different viral proteins. In addition, the functional characterization of Omicron VOC spike mutations was finely discussed according to published manuscripts. Lastly, residues characterizing the Omicron VOC and the previous four VOCs (Alpha, Beta, Gamma, and Delta) were mapped on the three-dimensional structure of the SARS-CoV-2 spike protein to assess their localization in the different spike domains. Overall, our study will assist with deciphering the Omicron VOC mutational profile and will shed more light on its clinical implications. This is critical considering that Omicron VOC is currently the predominant variant worldwide. IMPORTANCE The Omicron variant of concern (VOC) has a peculiar spectrum of mutations characterized by the acquisition of mutations or deletions rarely detected in previously identified variants, particularly in the spike glycoprotein. Such mutations, mostly residing in the receptor-binding domain, could play a pivotal role in enhancing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectivity (by increasing binding affinity for ACE2), jeopardizing spike recognition by therapeutic and vaccine-induced antibodies and causing diagnostic assay failure. To our knowledge, this is one of the first exhaustive descriptions of newly emerged mutations underlying the Omicron VOC and its biological and clinical implications.

Keywords: B.1.1.519; COVID-19; SARS-CoV-2; emerging variants; mutations; omicron; pandemic; variant of concern.
 
Back
Top Bottom